glp-1 wegovy Novo Nordisk launches weight-loss pill in US, triggering price war | Pharmaceuticals industry Wegovy Pill Wins FDA Approval
Description
But the drug helped
Reuters coverage: Novo Nordisk Files Patent Infringement Lawsuit At the same time, on Monday, Feburary 9, 2026, Novo Nordisk filed a patent infringement lawsuit against Hims & Hers , alleging that the telehealth companys compounded products infringe U.S
Employer plans may be more likely to cover drugs for weight loss than ACA Marketplace plans given the desire to attract workers, though they may employ similar utilization management strategies
Changes in blood pressure: Both elevation and reduction have been noted
